Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating serplulimab in combination with chemotherapy and concurrent radiotherapy for Limited-Stage Small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Limited-Stage Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING